Locations:

Tumor Oncology

March 4, 2019/Cancer/Tumor Oncology

More Therapies to Consider for Advanced and Refractory Renal Cell Carcinoma

Results of two studies presented at 2019 ASCO GU

February 16, 2019/Cancer/Tumor Oncology

KEYNOTE-426: Pembrolizumab + Axitinib or Sunitinib Alone for Advanced Renal Cell Carcinoma?

Combo therapy shows longer OS and PFS and higher ORR

January 4, 2019/Cancer/Tumor Oncology

SELECT Trial Finds TKIs Delay Recurrence but May Not Improve Cure Rate

More time on drug may be needed

December 7, 2018/Cancer/Tumor Oncology

Breast Reconstruction Complications Not Linked to Breast Cancer Recurrence

Tumor factors are more significant, says new study

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 3 of 3Next